Paul T. Quinlan
General Counsel · Oruka Therapeutics, Inc.
IndividualSelling only16 10b5-1 trades
- 2026
- Sep 21, 2026
- 6
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Paul T. Quinlan files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Fairmount Funds Management LLC - $300.01M in ORKA purchases and sales in the last 12 months
- Lawrence Otto Klein - $9.40M in ORKA purchases and sales in the last 12 months
- Carl Dambkowski - $8.65M in ORKA purchases and sales in the last 12 months
- Arjun Agarwal - $5.14M in ORKA purchases and sales in the last 12 months
- Joana Goncalves - $4.54M in ORKA purchases and sales in the last 12 months
- Laura Lee Sandler - $1.94M in ORKA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Paul T. Quinlan?
Paul T. Quinlan is a corporate insider, tracked as General Counsel of Oruka Therapeutics, Inc. (ORKA). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Paul T. Quinlan submitted recently?
3 primary Form 4 filings in the last 90 days, covering 1 company.
Has Paul T. Quinlan been buying or selling stock?
Recorded transactions: 0 open-market purchases and 13 open-market sales ($6.76M) across all tracked filings.
